Global B Streptococcus (GBS) Infection Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Prenatal-onset GBS Disease
1.2.3 Early-onset GBS Disease
1.2.4 Late-onset GBS Disease
1.3 Market by Application
1.3.1 Global B Streptococcus (GBS) Infection Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global B Streptococcus (GBS) Infection Treatment Market Size (2017-2028)
2.2 B Streptococcus (GBS) Infection Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global B Streptococcus (GBS) Infection Treatment Market Size by Region (2017-2022)
2.4 Global B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2023-2028)
2.5 Global Top B Streptococcus (GBS) Infection Treatment Countries Ranking by Market Size
3 B Streptococcus (GBS) Infection Treatment Competitive by Company
3.1 Global B Streptococcus (GBS) Infection Treatment Revenue by Players
3.1.1 Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2017-2022)
3.1.2 Global B Streptococcus (GBS) Infection Treatment Market Share by Players (2017-2022)
3.2 Global B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by B Streptococcus (GBS) Infection Treatment Revenue
3.4 Global B Streptococcus (GBS) Infection Treatment Market Concentration Ratio
3.4.1 Global B Streptococcus (GBS) Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B Streptococcus (GBS) Infection Treatment Revenue in 2021
3.5 Global B Streptococcus (GBS) Infection Treatment Key Players Head office and Area Served
3.6 Key Players B Streptococcus (GBS) Infection Treatment Product Solution and Service
3.7 Date of Enter into B Streptococcus (GBS) Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global B Streptococcus (GBS) Infection Treatment Breakdown Data by Type
4.1 Global B Streptococcus (GBS) Infection Treatment Historic Revenue by Type (2017-2022)
4.2 Global B Streptococcus (GBS) Infection Treatment Forecasted Revenue by Type (2023-2028)
5 Global B Streptococcus (GBS) Infection Treatment Breakdown Data by Application
5.1 Global B Streptococcus (GBS) Infection Treatment Historic Market Size by Application (2017-2022)
5.2 Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
6.2 North America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
6.3 North America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
6.4 North America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
7.2 Europe B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
7.3 Europe B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
7.4 Europe B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
8.2 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
8.3 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
8.4 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
9.2 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
9.3 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
9.4 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
10.2 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
10.3 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
10.4 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Products and Services
11.1.4 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.1.5 Pfizer Inc. B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.1.6 Pfizer Inc. Recent Developments
11.2 Alopexx Pharmaceuticals, LLC
11.2.1 Alopexx Pharmaceuticals, LLC Company Details
11.2.2 Alopexx Pharmaceuticals, LLC Business Overview
11.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Products and Services
11.2.4 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.2.5 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.2.6 Alopexx Pharmaceuticals, LLC Recent Developments
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Details
11.3.2 Wellstat Vaccines LLC Business Overview
11.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Products and Services
11.3.4 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.3.5 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.3.6 Wellstat Vaccines LLC Recent Developments
11.4 Minervax ApS
11.4.1 Minervax ApS Company Details
11.4.2 Minervax ApS Business Overview
11.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Products and Services
11.4.4 Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.4.5 Minervax ApS B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.4.6 Minervax ApS Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis B Streptococcus (GBS) Infection Treatment Products and Services
11.5.4 Novartis B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.5.5 Novartis B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.5.6 Novartis Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Products and Services
11.6.4 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.6.5 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.6.6 GlaxoSmithKline Recent Developments
12 B Streptococcus (GBS) Infection Treatment Market Dynamics
12.1 B Streptococcus (GBS) Infection Treatment Market Trends
12.2 B Streptococcus (GBS) Infection Treatment Market Drivers
12.3 B Streptococcus (GBS) Infection Treatment Market Challenges
12.4 B Streptococcus (GBS) Infection Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Prenatal-onset GBS Disease
Table 3. Key Players of Early-onset GBS Disease
Table 4. Key Players of Late-onset GBS Disease
Table 5. Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global B Streptococcus (GBS) Infection Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global B Streptococcus (GBS) Infection Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Region (2017-2022)
Table 9. Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global B Streptococcus (GBS) Infection Treatment Market Share by Players (2017-2022)
Table 11. Global Top B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Streptococcus (GBS) Infection Treatment as of 2021)
Table 12. Ranking of Global Top B Streptococcus (GBS) Infection Treatment Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players B Streptococcus (GBS) Infection Treatment Product Solution and Service
Table 16. Date of Key Manufacturers Enter into B Streptococcus (GBS) Infection Treatment Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2022)
Table 20. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2023-2028)
Table 22. Global B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2022)
Table 24. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2023-2028)
Table 26. North America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 61. Pfizer Inc. Company Details
Table 62. Pfizer Inc. Business Overview
Table 63. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product and Services
Table 64. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 65. Pfizer Inc. B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 66. Pfizer Inc. Recent Developments
Table 67. Alopexx Pharmaceuticals, LLC Company Details
Table 68. Alopexx Pharmaceuticals, LLC Business Overview
Table 69. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product and Services
Table 70. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 71. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 72. Alopexx Pharmaceuticals, LLC Recent Developments
Table 73. Wellstat Vaccines LLC Company Details
Table 74. Wellstat Vaccines LLC Business Overview
Table 75. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product and Services
Table 76. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 77. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 78. Wellstat Vaccines LLC Recent Developments
Table 79. Minervax ApS Company Details
Table 80. Minervax ApS Business Overview
Table 81. Minervax ApS B Streptococcus (GBS) Infection Treatment Product and Services
Table 82. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 83. Minervax ApS B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 84. Minervax ApS Recent Developments
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis B Streptococcus (GBS) Infection Treatment Product and Services
Table 88. Novartis B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 89. Novartis B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 90. Novartis Recent Developments
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product and Services
Table 94. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 95. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 96. GlaxoSmithKline Recent Developments
Table 97. B Streptococcus (GBS) Infection Treatment Market Trends
Table 98. B Streptococcus (GBS) Infection Treatment Market Drivers
Table 99. B Streptococcus (GBS) Infection Treatment Market Challenges
Table 100. B Streptococcus (GBS) Infection Treatment Market Restraints
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of FiguresFigure 1. Global B Streptococcus (GBS) Infection Treatment Sales Market Share by Type: 2021 VS 2028
Figure 2. Prenatal-onset GBS Disease Features
Figure 3. Early-onset GBS Disease Features
Figure 4. Late-onset GBS Disease Features
Figure 5. Global B Streptococcus (GBS) Infection Treatment Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 10. Global B Streptococcus (GBS) Infection Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global B Streptococcus (GBS) Infection Treatment Market Size 2017-2028 (US$ Million)
Figure 12. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 B Streptococcus (GBS) Infection Treatment Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global B Streptococcus (GBS) Infection Treatment Market Share by Players in 2021
Figure 16. Global Top B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Streptococcus (GBS) Infection Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue in 2021
Figure 18. North America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 19. North America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 20. North America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 21. North America B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 22. U.S. B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 23. Canada B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 24. Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 25. Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 26. Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 27. Europe B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 28. Germany B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 29. France B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 31. Italy B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 32. Russia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 34. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Share by Region (2017-2028)
Figure 37. China B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 38. Japan B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 40. India B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 41. Australia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 49. Latin America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 50. Latin America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 51. Latin America B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 52. Mexico B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 59. Turkey B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. UAE B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. Pfizer Inc. Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 63. Alopexx Pharmaceuticals, LLC Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 64. Wellstat Vaccines LLC Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 65. Minervax ApS Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 66. Novartis Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 67. GlaxoSmithKline Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed